Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 

QPP Measure #PIMSH13

Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy

Proportion of stage IV nsNSCLC patients tested for actionable biomarkers and received targeted therapy or chemotherapy based on biomarker results

Submission Methods: Registry

The following codes apply for this QPP measure:

HCPCS Codes

CodeDescription
M0001Advancing cancer care mips value pathways
demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.